Skip to content

Comparative study of the effects of neostigmine and sugammadex on cerebral blood flow and the incidence of hyperperfusion in patients undergoing carotid endarterectomy during recovery from general anesthesia

Comparative study of the effects of neostigmine and sugammadex on cerebral blood flow and the incidence of hyperperfusion in patients undergoing carotid endarterectomy during recovery from general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078579
Enrollment
Unknown
Registered
2023-12-13
Start date
2023-12-15
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid stenosis/Internal carotid stenosis

Interventions

sugammadex group:sugammadex (2mg/kg) will be given at TOFc=2 after surgery
neostigmine + atropine group:neostigmine (0.02mg/kg) + Atropine (0.01mg/kg) will be given at TOFc=2 after surgery

Sponsors

Xuanwu Hospital of CCMU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age 18 years or older, diagnosed with carotid artery stenosis; Patients undergoing endotracheal intubation under general anesthesia; Patients who received the non-depolarizing muscle relaxant rocuronium bromide during surgery; The American Society of Anesthesiologists (ASA) has a body condition rating of I to III.

Exclusion criteria

Exclusion criteria: Patients with severe abnormalities of heart, lung, liver or kidney function; Patients with neuromuscular dysfunction due to various reasons; Patients with neuromuscular block contraindications and hypersensitivity to neostigmine or sugen sodium; Intraoperative massive bleeding and malignant arrhythmia caused by various reasons; Changes in surgical procedures (including patients using a bypass tube during surgery, patients requiring carotid stent placement after CEA, and patients undergoing hybridization (CEA+ angiography); After the operation, the recovery was delayed, and the duration of extubation was =30 min. Patients who are participating in other studies or who declined to participate in this study; Patients undergoing other procedures at the same time; Patients who lost follow-up.

Design outcomes

Primary

MeasureTime frame
The difference of cerebral blood flow fluctuation between neostigmine group and sugenose sodium group during recovery;

Secondary

MeasureTime frame
extubation time;The fluctuation of arterial blood pressure during extubation between groups;Heart rate fluctuation during extubation between groups;Differences in incidence of diencephalic hyperperfusion between groups;Differences in incidence of hypoxemia between groups;Differences in the incidence of hypercapnia between groups;Differences in the incidence of postoperative pulmonary complications between groups;Differences in the incidence of postoperative adverse cardiac events between groups;Differences in the incidence of postoperative neurological complications between groups;Eye opening time;Duration of stay in anesthesia recovery room;Postoperative hospital stay;Dosage of vasoactive drugs such as deoxyadrenalin, urapidil, nicardipine, esmolol during extubation;

Countries

China

Contacts

Public ContactZhao Lei

Xuanwu Hospital of CCMU

zhaoalei@sina.com.cn+86 138 1103 5886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026